iiinova — where your digital self keeps evolving

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 16/10/2026

🔬 Fully-funded 4-yr PhD opportunity @NewcastleUni! Investigate early-life exposures & childhood leukaemia epigenomics with Prof Lisa J Russell. Open to Black heritage graduates. Co-delivered with Black in Cancer and the Windsor Fellowship. Apply here: www.ncl.ac.uk/cancer/train... #PhDOpportunity

ncl.ac.uk

CRUK Black Leaders PhD Scholarship | Centre for Cancer | Newcastle University

032 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 16/10/2026

Curious about childhood cancer research? Join us for a FREE Research Evening @NewcastleUni on 12 November! 🧬 Discover cutting-edge science, meet researchers and enjoy interactive activities. 📍Herschel Building | 3:45–8pm Book: www.eventbrite.co.uk/e/revolution... #ChildhoodCancerResearch

eventbrite.co.uk

Revolutionary Research into Childhood Cancer - A Public Engagement Event

Join us to explore the progress and discoveries that are leading the way in childhood cancer research at Newcastle University.

032 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 12/10/2026

Remembering Ruby #LiveKindly,LiveLoudly This week the LEGEND group took some time out in memory of Ruby, on what would have been her 25th Birthday to share some chocolate cake. We are immensely grateful for support from Ruby's Fund, and aim to continue her legacy through our work❤️

The LEGEND group, sharing chocolate cake in memory of Ruby on what would have been her 25th Birthday.

032 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 06/10/2026

🧬 Research Technician Opportunity 🧬 Looking to contribute to cutting-edge paediatric leukaemia research funded by @cancerresearchuk.org using advanced epigenomics and CRISPR methods? The LEGEND group is hiring, join the team! 🔬 Full details in the link 👇 bit.ly/3VOQipJ%E2%8...

The LEGEND group in the lab, at the Wolfson Childhood Cancer Research Centre, Newcastle University.

035 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 02/10/2026

Last month, @letimarchetti.bsky.social gave an introduction to our research to the team at Leica Biosystems. It was a great opportunity to share our work, discuss our research, and exchange ideas. Thank you to Leica and @childcancernth.bsky.social for the invitation and the engaging discussions!

033 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 01/10/2026

Delighted to share that LEGEND Group Leader, Lisa Russell, has been promoted to Professor of Cancer Epigenomics! 🎉🧬 A milestone built on hard work, dedication, an amazing team, awesome support — and a healthy dose of good fortune. Excited for what comes next! 🔬

043 4

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 18/09/2026

This Blood Cancer Awareness Month, we stand alongside patients, families, clinicians and researchers working towards a future where blood cancers are detected earlier, treated and ultimately prevented. Every discovery starts with research at the bench 🧪🩸 #BloodCancerAwarenessMonth

Thank you to Martin Newman for capturing our research in the lab.

044 4

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 11/09/2026

We’re glad to have participated in the 23rd CLR-UK Annual Meeting in Nottingham! It was a great opportunity to share our research, contribute to organising the meeting, exchange ideas, and network with fellow scientists working in childhood leukaemia research. #CLRUK2026 #BCUK

033 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/09/2026

A multicultural lab group comes with so many advantages! We don’t only share valuable ideas and different prospective, but we also get to share traditional food and learn about each other's cultures. Thanks @alsayadi.bsky.social for introducing us to Arabic coffee and sharing sweet treats!

Arabic coffee, dates and traditional sweet treats.

055 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 31/07/2026

This week @dr-ahlamq.bsky.social has been preparing DNA for long-read sequencing. Historically, DNA is broken into 'chunks' to read the code. Long-read sequencing is newer technology for deciphering much longer stretches of DNA, providing in-depth information about leukaemia genetics.

Dr Ahlam Alqahtani is carefully examining a tube containing DNA that has been extracted for long-read sequencing technologies.

The long strands of DNA 'wrap-around' glass beads within the tube, enabling us to extract much longer DNA strands than traditional methods.

053 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 24/07/2026

Proud supervisor moment for @drnickbrittain.bsky.social & @letimarchetti.bsky.social attending the MRes Poster session and supporting Lucy and Kunwoo, amazing intercalating medics who worked with @ljrusselllab.bsky.social over the last 5 months on their research project. Best luck and AD MAIORA!

020 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 16/07/2026

Today we had the pleasure to host @stefanschoenfelder.bsky.social at @newcastleuni.bsky.social who gave a brilliant and insightful talk about non canonical enhancers and reset in induced pluripotent stem cells. Thank you to everyone who joined the seminar and for the great discussion at the end!

021 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 12/06/2026

Great conference this week, filled with inspiring talks and poster presentations from @nucancer.bsky.social researchers. Congratulations to our PhDs, @phoebejsnow.bsky.social & @alsayadi.bsky.social, recipients of PGR Outstanding Contribution Awards in recognition of their hard work and dedication.

061 6

Reposted by LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group

Newcastle University Centre for Cancer @nucancer.bsky.social · 12/06/2026

Congratulations to our PhD students Ahmed Alsayadi, Phoebe Snow and Emma Barlow on receiving FMS Postgraduate Outstanding Contribution Awards, recognising their outstanding contributions to the NUCancer PGR community. A brilliant achievement and very well deserved 👏

022 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/06/2026

@letimarchetti.bsky.social represented the LEGEND group at the 'Young Researchers Chromatin Club' seminar series by @activemotifusa.bsky.social Leti presented exciting research progress, using multiple chromatin profiling methods to understand genetic regulation in leukaemia.

A picture of Leti's online Young Researchers Chromatin Club seminar on Zoom, viewed by a laptop of a LEGEND group member.

052 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 05/05/2026

This competitively funded PhD opportunity has an application deadline of 20th May 🔬🧬

010 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 05/05/2026

🧬 Fighting Paediatric Leukaemia with Epigenetics: 4-Year PhD Opportunity! Looking to push the boundaries of cancer research using cutting-edge epigenomic technology? We are seeking a dedicated PhD student to join the LEGEND group. Full details in the link below: bit.ly/LEGEND_PhD

The LEGEND group in the lab.
From left to right: Dr Ahlam Alqahtani, Dr Nicholas Brittain, Dr Letizia Marchetti, Camille Drai, Dr Lisa Russell (group leader), Ahmed Alsayadi, Phoebe Snow

134 4

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 30/03/2026

Last week was an exciting one for the LEGEND Group! We attended NUBI Live, where Lisa and Phoebe gave talks, and Ahmed and Leti presented posters. Nick also presented in the @nucancer.bsky.social PMGI Symposium. Excellent science with plenty of engaging discussions!

062 6

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 21/03/2026

Very proud that LEGEND Group technician, Camille Drai, won two prestigious Techncian Awards. Well done @camilledrai.bsky.social 👏

072 7

Reposted by LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group

Blood Cancer UK @bloodcanceruk.bsky.social · 11/02/2026

Research looks like... Dr Jasmeen Oberoi: "Collaboration from researchers, healthcare professionals and people with lived experience." Dr Lisa Russell: "Teamwork between researchers and clinicians, turning lab discoveries into real treatments for people who need them."

Image is of Dr Jasmeen Oberoi in a burgundy lab coat and gloves using a pipette in a lab setting looking down at what she's doing

Image of Dr Lisa Russel looking into a microscope wearing a white lab coat and blue gloves with a colleague behind looking over her shoulder

041 4

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/02/2026

Today is #WorldCancerDay. We honour everyone affected by cancer - patients, families, and loved ones ❤️ Today is a reminder of why we do what we do, to make a difference through research.

001 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 12/12/2025

Molly’s story is a powerful reminder of why we are committed to fighting leukaemia. Every donation supports better treatment development. bloodcancer.org.uk/get-involved... Not only does research continue to grow, but our @bloodcanceruk.bsky.social project plant grows alongside it, a symbol of hope.

021 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 19/11/2025

Shout out this #InternationalMensDay to Ahmed Alsayadi (@alsayadi.bsky.social) and Nick Brittain — brilliant cancer researchers and all-round great humans. Your skill, drive, and good vibes make the LEGEND team what it is 💙

Ahmed is happily working away in our tissue culture lab

Nick is working in the lab pipetting reagents for his current experiment.

064 6

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 17/11/2025

We’re excited to welcome a talented new postdoctoral researcher, Monika Gonka, to the LEGEND group! She’ll be leading data-driven projects and supporting the team as a bioinformatics research assistant. Welcome aboard, Monika!

083 8

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 01/11/2025

I was welcomed to the lab meeting yesterday by this spooky bunch 🤪. Always up for a giggle and certainly made my day 😆

052 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 13/10/2025

Getting this right enhances our ability to study specific regions of the genome, helping us to gain further insights into leukaemia biology and ultimately discover novel ways it may be targeted.

010 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 13/10/2025

Viruses effectively deliver gene-editing proteins into leukaemia cells. Envelope proteins ‘coat’ the virus, and the best envelope choice can vary between different leukaemias. We use fluorescent dyes to decide which envelope will allow the best delivery of the gene-editing proteins to the cells.

Here one of our team members, Dr Nicholas Brittain, is pointing to a green cell that has successfully taken up the gene-editing proteins.

120 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 30/09/2025

Together with @avmoorman.bsky.social, we will lead the two research projects that will explore the biology of ALL and how we can use that information to find the most effective treatments and reduce the challenging long-term side effects of chemotherapy.

000 0

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 30/09/2025

Two research projects at Newcastle University are celebrating £4.1million of investment from Cancer Research UK to explore how children with ALL, the same cancer Dan had, can be diagnosed and treated more effectively to improve survival rates.

100 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 28/09/2025

Last week on #WorldCancerResearchDay the whole lab and other colleagues from @nucancer.bsky.social turned into bakers to help fundraising for @cancerresearchuk.org, a charity close to us for their commitment to fund groundbreaking projects in cancer research. Lovely seeing the public engaged!

032 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 19/09/2025

September is #ChildhoodCancerAwarenessMonth. Our team joined the @childcancernth.bsky.social campaign #PaintTheToonGold to show support for children with cancer and their families. Together, we can raise awareness and keep pushing research forward.

164 6

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 12/09/2025

We were excited to share our recent research findings and projects at #CLRUK25 in York. Dr. Brittain and Dr. Alqahtani were thrilled to present their projects, supported by @cancerresearchuk.org and @bloodcanceruk.bsky.social. Dr. Marchetti brought great energy while chairing the first session.

@letimarchetti.bsky.social and Frederik van Delft are chairing the first session at CLRUK25

Dr. Nicholas Brittain is presenting his CR_UK funded project titled (Mechanistic investigation of super-enhancer dynamics in B-ALL)

@dr-ahlamq.bsky.social is presenting her BloodCancer_UK funded project titled (Investigating the consequences of CEBP dysregulation in acute lymphoblastic leukaemia)

031 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 11/09/2025

Morning coffee and train for the whole lab today, direction #CLRUK25 in York! Looking forward to seeing everyone from the CLR-UK network! #ChildhoodCancerAwarenessMonth #BloodCancerAwarenessMonth

042 4

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 04/09/2025

Research is not a solo effort. It takes teamwork. It takes belief. It takes collaboration. We know what it takes to beat blood cancer and so does @dr-ahlamq.bsky.social whose work is funded by @bloodcanceruk.bsky.social grant co-led by Lisa & @letimarchetti.bsky.social #BloodCancerAwarenessMonth

Lisa is the Principal Investigator of the group
but she still enjoys spending time in the lab to drive
the work to beat blood cancer.

053 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 08/08/2025

Dr Brittain says "I am really excited to have joined the @ljrusselllab.bsky.social group within @nucancer.bsky.social. I look forward to applying the variety of cutting-edge epigenomic techniques used within the group as we continue to deepen our understanding of super- enhancer biology"

010 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 08/08/2025

We recently welcomed Dr Nicholas Brittain to the LEGEND group, who has joined as a Research Associate to investigate mechanisms driving super-enhancers in paediatric leukaemia as part of a research project funded by @cancerresearchuk.org

152 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 08/08/2025

Recent nice weather called for a social outing of the LEGEND group, filled with fun, sport and a MUST stop for ice cream by the coast 🍦. We also had our first lab retreat at Cockle Park, featuring good scientific discussion 🧬 and a visit by our @ukri.org MRC collaborators from Edinburgh ✨

Deserved rest after an exciting volleyball tournament

Ice-cream is the best way to end a great social outing with the lab

The group got bigger! We count, from the left: Camille (Research Technician), Ahmed (PhD student), Leti (PostDoc), Lisa (Group Leader), Ahlam (PostDoc), Nick (PostDoc) and Phoebe (PhD student)

MRC collaborators from Edinburgh, Chris A.Brackley (left) and Rodrigo Rivas Barbosa (right)

054 5

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 07/08/2025

It even made the News and Views section on the Nature website which provides a lovely overview of the paper. [nature.com/articles/d41586-025-0242…].

010 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 07/08/2025

Thrilled to have contributed to ground-breaking research led by Dr Joan Boyes (@universityofleeds.bsky.social‬), just out in Nature (‪@nature.com‬)! 🧬 We show that tiny DNA fragments, naturally cut from the genome, can linger—causing more damage & helping leukaemia progress.

Dr Zeqian Gao, Dr Joan Boyes, and Dylan Casey (PhD student) in the lab

133 3

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 08/07/2025

Our lab was delighted to host a visit from @cancerresearchuk.org fundraisers, campaigners, and patient advocates Sue Duncombe and Patrick McGuire. It was a pleasure to share our research, to give an insight into our daily work and highlight how CRUK support helps us move science forward.

Camille is showing how the transfected cell lines appear under a florescent microscope

Ahmed and Nick are explaining how we visualize genome editing using gel electrophoresis

Ahmed and Nick are explaining the technical aspect of using gel electrophoresis

Leti is explaining how we use blood cancer cell lines to explore options for better therapy interventions

043 4

Reposted by LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group

Children's Cancer North @childcancernth.bsky.social · 28/04/2025

🌟 Nominate Children’s Cancer North for a chance to win £5,000! The Benefact Movement for Good Health & Wellbeing Special Draw is open until May 4. By nominating us, Children’s Cancer North could win £5,000 to help make life better for children and young people affected by cancer 👉 loom.ly/dFhKtac

loom.ly

Nominate a charity - Movement for Good

Nominate a charity for a Movement for Good award now.

011 1

Reposted by LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group

Letizia Marchetti @letimarchetti.bsky.social · 10/06/2025

Having a great day with the whole @ljrusselllab.bsky.social group, attending the @nucancer.bsky.social 2025 conference, showcasing excellent research from across the faculty, including some of our own from the #WolfsonCentre in the Herschel building, Alistair Poll and Melvin Joy. More to come later!

032 3

Reposted by LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group

Camille Drai @camilledrai.bsky.social · 11/06/2025

@ljrusselllab.bsky.social has crafted beautiful items for Children's Cancer North! If you want to help this amazing charity, have a look at the shop : Lunch Bag: shorturl.at/jvdLm Phone Holder: shorturl.at/QbFXN Pouch: shorturl.at/ryX6x

childrenscancernorth.org.uk

CCN Lunch Bag - Children's Cancer North

With this CCN lunch bag, you’re not only getting a beautifully hand-crafted accessory but also helping fund vital research and support children with cancer

011 1

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 10/06/2025

Great poster session by the LEGEND team. Lots of informative discussions had with other @nucancer.bsky.social colleagues.

020 2

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 10/06/2025

Great morning had at the @nucancer.bsky.social conference. Proud to see the work of the team presented as recent success stories coming from the centre.

000 0

LEGEND: Leukaemia EpiGenomic & ENhancer Dysregulation group @ljrusselllab.bsky.social · 23/05/2025

First time running a "Meet the Expert" session today at the European School for Haematology. Despite being nervous and not really knowing what to expect, I thoroughly enjoyed myself. I had a lovely group of attendees who made the experience one to remember.

020 2